UPMC Harrisburg is a 409-bed urban hospital in Harrisburg, Pennsylvania and part of the University of Pittsburgh Medical Center system. The hospital serves as the hub for the UPMC network, providing advanced care to the residents throughout southcentral Pennsylvania.

There are 409 beds in UPMC Pinnacle Harrisburg.

During the past decade, UPMC Pinnacle Harrisburg conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 30 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 18 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Pinnacle Harrisburg" #1 sponsor was "Abbott Medical Devices" with 23 trials, followed by "Medtronic Cardiovascular" with 12 trials sponsored, "Boston Scientific Corporation" with 8 trials sponsored, "National Cancer Institute (NCI)" with 8 trials sponsored and "Alliance for Clinical Trials in Oncology" with 8 trials sponsored. Other sponsors include 52 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Pinnacle Harrisburg" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Pinnacle Harrisburg" are "Coronary Artery Disease" (12 trials), "Atrial Fibrillation" (7 trials), "Coronary Disease" (6 trials), "Aortic Valve Stenosis" (5 trials) and "Carotid Artery Disease" (5 trials). Many other conditions were trialed in "UPMC Pinnacle Harrisburg" in a lesser frequency.

Most popular intervention types in "UPMC Pinnacle Harrisburg" are "Device" (64 trials), "Drug" (45 trials), "Procedure" (17 trials), "Other" (12 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Cisplatin" (5 trials), "Computed Tomography" (5 trials), "Paclitaxel" (5 trials) and "Biospecimen Collection" (4 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Pinnacle Harrisburg" are 111 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "UPMC Pinnacle Harrisburg". undefined are not yet recruiting, 25 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in UPMC Pinnacle Harrisburg, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Pinnacle Harrisburg, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 51 trials that are defined as “Not Applicable".